Evidence map›Paper›PMID 36984055›Full record

ArticleMaterials (Basel, Switzerland)2023

Combined Femtosecond Laser Glass Microprocessing for Liver-on-Chip Device Fabrication.

Agnė Butkutė, Tomas Jurkšas, Tomas Baravykas, Bettina Leber, Greta Merkininkaitė, Rugilė Žilėnaitė, Deividas Čereška, Aiste Gulla, Mindaugas Kvietkauskas, Kristina Marcinkevičiūtė and 2 more

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Agnė ButkutėFemtika Ltd., Keramikų Str. 2, LT-10233 Vilnius, Lithuania.ORCID 0000-0002-2616-0577
Tomas JurkšasFemtika Ltd., Keramikų Str. 2, LT-10233 Vilnius, Lithuania.
Tomas BaravykasFemtika Ltd., Keramikų Str. 2, LT-10233 Vilnius, Lithuania.
Bettina LeberGeneral, Visceral and Transplant Surgery, Department of Surgery, Medical University of Graz, Auenbruggerplatz 29, AT-8036 Graz, Austria.ORCID 0000-0002-2101-7560
Greta MerkininkaitėFemtika Ltd., Keramikų Str. 2, LT-10233 Vilnius, Lithuania.
Rugilė ŽilėnaitėFemtika Ltd., Keramikų Str. 2, LT-10233 Vilnius, Lithuania.ORCID 0000-0002-4544-1964
Deividas ČereškaFemtika Ltd., Keramikų Str. 2, LT-10233 Vilnius, Lithuania.
Aiste GullaInstitute of Clinical Medicine, Faculty of Medicine, Center of Visceral Medicine and Translational Research, Vilnius University, M. K. Čiurlionio g. 21, LT-03101 Vilnius, Lithuania.ORCID 0000-0003-2433-3603
Mindaugas KvietkauskasInstitute of Clinical Medicine, Faculty of Medicine, Center of Visceral Medicine and Translational Research, Vilnius University, M. K. Čiurlionio g. 21, LT-03101 Vilnius, Lithuania.ORCID 0000-0001-6789-6137
Kristina MarcinkevičiūtėInstitute of Clinical Medicine, Faculty of Medicine, Center of Visceral Medicine and Translational Research, Vilnius University, M. K. Čiurlionio g. 21, LT-03101 Vilnius, Lithuania.ORCID 0000-0002-6821-8925
Peter SchemmerGeneral, Visceral and Transplant Surgery, Department of Surgery, Medical University of Graz, Auenbruggerplatz 29, AT-8036 Graz, Austria.ORCID 0000-0002-4192-6155
Kęstutis StrupasInstitute of Clinical Medicine, Faculty of Medicine, Center of Visceral Medicine and Translational Research, Vilnius University, M. K. Čiurlionio g. 21, LT-03101 Vilnius, Lithuania.ORCID 0000-0002-1690-937X

Funding

European Commission 01.2.2-MITA- 211 K-702-10-0006.
6 · The paper itself

Abstract

Nowadays, lab-on-chip (LOC) devices are attracting more and more attention since they show vast prospects for various biomedical applications. Usually, an LOC is a small device that serves a single laboratory function. LOCs show massive potential for organ-on-chip (OOC) device manufacturing since they could allow for research on the avoidance of various diseases or the avoidance of drug testing on animals or humans. However, this technology is still under development. The dominant technique for the fabrication of such devices is molding, which is very attractive and efficient for mass production, but has many drawbacks for prototyping. This article suggests a femtosecond laser microprocessing technique for the prototyping of an OOC-type device-a liver-on-chip. We demonstrate the production of liver-on-chip devices out of glass by using femtosecond laser-based selective laser etching (SLE) and laser welding techniques. The fabricated device was tested with HepG2(GS) liver cancer cells. During the test, HepG2(GS) cells proliferated in the chip, thus showing the potential of the suggested technique for further OOC development.

Indexed as

3D laser microfabricationfemtosecond laser microprocessingglass microfluidicslaser weldingselective laser etching

Identifiers

PMID36984055
PMCPMC10056550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.